Foresite Capital Management III, LLC - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 1 filers reported holding AKARI THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Foresite Capital Management III, LLC ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q4 2016$1,387,000
-17.3%
197,0720.0%0.60%
-23.1%
Q3 2016$1,677,000
-36.9%
197,0720.0%0.78%
-57.0%
Q2 2016$2,659,000
-28.0%
197,072
-25.3%
1.82%
-36.2%
Q1 2016$3,695,000
-3.4%
263,9210.0%2.86%
-15.8%
Q4 2015$3,827,000263,9213.39%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
VHCP Management II, LLC 426,297$1,965,0000.78%
Vivo Capital, LLC 527,842$2,433,0000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 818,158$3,772,0000.20%
NEA Management Company, LLC 452,167$2,084,0000.08%
Hikari Power Ltd 60,012$277,0000.04%
Baker Brothers Advisors 496,901$2,291,0000.02%
QVT Financial LP 132,077$531,0000.01%
MILLENNIUM MANAGEMENT LLC 214,126$987,0000.00%
Virtu KCG Holdings LLC 12,472$57,0000.00%
Advisor Group, Inc. 6,381$29,0000.00%
View complete list of AKARI THERAPEUTICS PLC shareholders